Universal and mutation-resistant anti-enteroviral activity

Potency of small interfering RNA complementary to the conserved cis-acting replication element within the enterovirus coding region

Hui Sun Lee, Jeonghyun Ahn, Youngmee Jee, Sun Seo, Eun Jung Jeon, Eun Seok Jeon, Chul Hyun Joo, Yoo Kyum Kim, Heuiran Lee

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The promising potential of RNA interference-based antiviral therapies has been well established. However, the antiviral efficacy is largely limited by genomic diversity and genetic instability of various viruses, including human enterovirus B (HEB). In this work, the first evidence supporting the anti-HEB activity of the small interfering RNA (siRNA) targeting the highly conserved cis-acting replication element (CRE) within virus coding region 2C is presented. HeLa cells pre-treated with siRNA complementary to the conserved sequence of the loop region of CRE(2C) were effectively rescued from the cytopathic effects of HEBs. Downregulation of virus replication and attenuation of cytotoxicity were consistently observed in various reference strains and clinical isolates. Cells treated with this siRNA were resistant to the emergence of viable escape mutants and showed sustained antiviral ability. Collectively, the data suggest that the siRNA based on the disordered structure within the highly conserved cis-acting coding region has potential as a universal, persistent anti-HEB agent. The same strategy can be successfully applied to the development of siRNA with consistent antiviral effects in other virus groups possessing similar RNA elements.

Original languageEnglish (US)
Pages (from-to)2003-2012
Number of pages10
JournalJournal of General Virology
Volume88
Issue number7
DOIs
StatePublished - Jul 1 2007
Externally publishedYes

Fingerprint

Enterovirus
Small Interfering RNA
Human Enterovirus B
Antiviral Agents
Mutation
Viruses
Conserved Sequence
Virus Replication
RNA Interference
HeLa Cells
Down-Regulation
RNA

ASJC Scopus subject areas

  • Virology

Cite this

Universal and mutation-resistant anti-enteroviral activity : Potency of small interfering RNA complementary to the conserved cis-acting replication element within the enterovirus coding region. / Lee, Hui Sun; Ahn, Jeonghyun; Jee, Youngmee; Seo, Sun; Jeon, Eun Jung; Jeon, Eun Seok; Joo, Chul Hyun; Kim, Yoo Kyum; Lee, Heuiran.

In: Journal of General Virology, Vol. 88, No. 7, 01.07.2007, p. 2003-2012.

Research output: Contribution to journalArticle

Lee, Hui Sun ; Ahn, Jeonghyun ; Jee, Youngmee ; Seo, Sun ; Jeon, Eun Jung ; Jeon, Eun Seok ; Joo, Chul Hyun ; Kim, Yoo Kyum ; Lee, Heuiran. / Universal and mutation-resistant anti-enteroviral activity : Potency of small interfering RNA complementary to the conserved cis-acting replication element within the enterovirus coding region. In: Journal of General Virology. 2007 ; Vol. 88, No. 7. pp. 2003-2012.
@article{fa8c23621178404f905003d4f3dc5dff,
title = "Universal and mutation-resistant anti-enteroviral activity: Potency of small interfering RNA complementary to the conserved cis-acting replication element within the enterovirus coding region",
abstract = "The promising potential of RNA interference-based antiviral therapies has been well established. However, the antiviral efficacy is largely limited by genomic diversity and genetic instability of various viruses, including human enterovirus B (HEB). In this work, the first evidence supporting the anti-HEB activity of the small interfering RNA (siRNA) targeting the highly conserved cis-acting replication element (CRE) within virus coding region 2C is presented. HeLa cells pre-treated with siRNA complementary to the conserved sequence of the loop region of CRE(2C) were effectively rescued from the cytopathic effects of HEBs. Downregulation of virus replication and attenuation of cytotoxicity were consistently observed in various reference strains and clinical isolates. Cells treated with this siRNA were resistant to the emergence of viable escape mutants and showed sustained antiviral ability. Collectively, the data suggest that the siRNA based on the disordered structure within the highly conserved cis-acting coding region has potential as a universal, persistent anti-HEB agent. The same strategy can be successfully applied to the development of siRNA with consistent antiviral effects in other virus groups possessing similar RNA elements.",
author = "Lee, {Hui Sun} and Jeonghyun Ahn and Youngmee Jee and Sun Seo and Jeon, {Eun Jung} and Jeon, {Eun Seok} and Joo, {Chul Hyun} and Kim, {Yoo Kyum} and Heuiran Lee",
year = "2007",
month = "7",
day = "1",
doi = "10.1099/vir.0.82633-0",
language = "English (US)",
volume = "88",
pages = "2003--2012",
journal = "Journal of General Virology",
issn = "0022-1317",
publisher = "Society for General Microbiology",
number = "7",

}

TY - JOUR

T1 - Universal and mutation-resistant anti-enteroviral activity

T2 - Potency of small interfering RNA complementary to the conserved cis-acting replication element within the enterovirus coding region

AU - Lee, Hui Sun

AU - Ahn, Jeonghyun

AU - Jee, Youngmee

AU - Seo, Sun

AU - Jeon, Eun Jung

AU - Jeon, Eun Seok

AU - Joo, Chul Hyun

AU - Kim, Yoo Kyum

AU - Lee, Heuiran

PY - 2007/7/1

Y1 - 2007/7/1

N2 - The promising potential of RNA interference-based antiviral therapies has been well established. However, the antiviral efficacy is largely limited by genomic diversity and genetic instability of various viruses, including human enterovirus B (HEB). In this work, the first evidence supporting the anti-HEB activity of the small interfering RNA (siRNA) targeting the highly conserved cis-acting replication element (CRE) within virus coding region 2C is presented. HeLa cells pre-treated with siRNA complementary to the conserved sequence of the loop region of CRE(2C) were effectively rescued from the cytopathic effects of HEBs. Downregulation of virus replication and attenuation of cytotoxicity were consistently observed in various reference strains and clinical isolates. Cells treated with this siRNA were resistant to the emergence of viable escape mutants and showed sustained antiviral ability. Collectively, the data suggest that the siRNA based on the disordered structure within the highly conserved cis-acting coding region has potential as a universal, persistent anti-HEB agent. The same strategy can be successfully applied to the development of siRNA with consistent antiviral effects in other virus groups possessing similar RNA elements.

AB - The promising potential of RNA interference-based antiviral therapies has been well established. However, the antiviral efficacy is largely limited by genomic diversity and genetic instability of various viruses, including human enterovirus B (HEB). In this work, the first evidence supporting the anti-HEB activity of the small interfering RNA (siRNA) targeting the highly conserved cis-acting replication element (CRE) within virus coding region 2C is presented. HeLa cells pre-treated with siRNA complementary to the conserved sequence of the loop region of CRE(2C) were effectively rescued from the cytopathic effects of HEBs. Downregulation of virus replication and attenuation of cytotoxicity were consistently observed in various reference strains and clinical isolates. Cells treated with this siRNA were resistant to the emergence of viable escape mutants and showed sustained antiviral ability. Collectively, the data suggest that the siRNA based on the disordered structure within the highly conserved cis-acting coding region has potential as a universal, persistent anti-HEB agent. The same strategy can be successfully applied to the development of siRNA with consistent antiviral effects in other virus groups possessing similar RNA elements.

UR - http://www.scopus.com/inward/record.url?scp=34347370518&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34347370518&partnerID=8YFLogxK

U2 - 10.1099/vir.0.82633-0

DO - 10.1099/vir.0.82633-0

M3 - Article

VL - 88

SP - 2003

EP - 2012

JO - Journal of General Virology

JF - Journal of General Virology

SN - 0022-1317

IS - 7

ER -